EGFR and lung adenocarcinoma: H441-L2G cells (lung adenocarcinoma cells with wild-type EGFR, which express the L2G fusion construct containing dual optical reporters (firefly luciferase 2 and eGFP)) were subcutaneously injected into NOD/SCID mice for in vivo validation of WA-mediated anticancer effects.